Back to catalog
CJC-1295 / Ipamorelin Astral research vial

CJC-1295 / Ipamorelin

Mod GRF(1–29) / Ipamorelin

A co-lyophilized blend of Mod GRF (1-29) and Ipamorelin, pairing a GHRH analog with a selective ghrelin-receptor peptide. Supplied for in-vitro GH-axis signaling research.

Mass

  • 5/5 mg$57.99In stock

From $57.99Purity 99.82%Third-party tested— View COA

View purchase options

Specifications

CJC-1295 / Ipamorelin — Specifications
CAS number863288-34-0 / 170851-70-4
Molecular formulaBlend
Molecular weight3367.97 + 711.85 g/mol
FormLyophilized powder
Purity (latest released COA)99.82% · AST-CP10-001
Net quantity5/5 mg / vial

Handling & storage

CJC-1295 / Ipamorelin — Handling & storage
GuidanceStore lyophilized powder at −20 °C, protected from light. After reconstitution with bacteriostatic water, store at 2–8 °C and use within 30 days. Every vial ships with a batch-specific Certificate of Analysis.
For laboratory research use only. Not a drug, food, cosmetic or supplement. Not for human or veterinary consumption, diagnosis, or treatment.

Documentation

Certificates of Analysis

Batch-specific, third-party lab certificates. Each COA is published here once its lot has been tested — preview the results, then open the full PDF.

Current released record

AST-CP10-001

Dosage
5/5 mg
Purity
99.82%
Laboratory
Janoshik
Analyzed
2026-07-30
Open source PDF

View the compound COA record →

Related peer-reviewed research

  1. Ipamorelin constituentIpamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology (1998)
  2. Ipamorelin constituentThe growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats. Growth Hormone & IGF Research (2001)